CIK 0001055726 · Non-accelerated filer<br>Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330969592
- Phone
- 8584103134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Shares withheld for taxes | −9,088 | $1.98 | $18K | 46,550 |
| 2025-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −5,852 | 0 | ||
| 2025-02-26 | Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise · Restricted Stock Unit | −18,632 | 37,263 | ||
| 2025-02-26 | KIES PETER CFO | Option exercise | +3,997 | 28,364 | ||
| 2025-02-26 | KIES PETER CFO | Shares withheld for taxes | −2,362 | $1.98 | $5K | 26,002 |
| 2025-02-26 | KIES PETER CFO | Option exercise | +5,010 | 31,012 | ||
| 2025-02-26 | KIES PETER CFO | Shares withheld for taxes | −2,960 | $1.98 | $6K | 28,052 |
| 2025-02-26 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −3,997 | 0 | ||
| 2025-02-26 | KIES PETER CFO | Option exercise · Restricted Stock Unit | −5,010 | 10,019 | ||
| 2025-02-26 | Weiner David B. Director | Option exercise | +972 | 83,481 | ||
| 2025-02-26 | Weiner David B. Director | Option exercise | +972 | 84,453 | ||
| 2025-02-26 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −972 | 0 | ||
| 2025-02-26 | Weiner David B. Director | Option exercise · Restricted Stock Unit | −972 | 972 | ||
| 2024-12-18 | Sumner Michael John Chief Medical Officer | Grant or award · Common Stock Option | +5,708 | 5,708 | ||
| 2024-12-18 | Sumner Michael John Chief Medical Officer | Grant or award · Restricted Stock Unit | +4,292 | 4,292 | ||
| 2024-06-30 | Sumner Michael John Chief Medical Officer | Option exercise | +2,917 | 8,219 | ||
| 2024-06-30 | Sumner Michael John Chief Medical Officer | Option exercise · Restricted Stock Unit | −2,917 | 2,916 | ||
| 2024-05-21 | Zoth Lota S. Director | Grant or award · Common Stock Options | +2,917 | 2,917 | ||
| 2024-05-21 | Zoth Lota S. Director | Grant or award · Restricted Stock Unit | +2,167 | 2,167 | ||
| 2024-05-21 | Shepard Jay Director | Grant or award · Common Stock Options | +2,917 | 2,917 |
Page 8 of 17 · 322 trades